Navigation Links
Nonin Medical, Inc. Showcases the First Pulse Oximeter Pre-Certified by the Continua Health Alliance
Date:10/31/2008

MINNEAPOLIS, Oct. 31 /PRNewswire/ -- Nonin Medical, Inc., a leading innovator of physiological monitoring solutions, successfully demonstrated the first Continua pre-certified pulse oximeter at the 5th Annual Connected Health Symposium in Boston, Massachusetts. By meeting Continua's comprehensive Version One guidelines, Nonin Medical's innovative pulse oximeters along with products from over 170 companies worldwide, will enable a simple "plug and play" integration -- resulting in streamlined communications to help consumers and healthcare providers better manage personal health and wellness.

Nonin Medical collaborated with other leading companies in recent months to successfully complete the international connectivity standard for the interoperability of pulse oximeters, ISO/IEEE 11073-10404. "This is a significant step toward eliminating proprietary interfaces, allowing pulse oximetry equipment to communicate freely with other devices," says Kurt Kermes, Standards Architect at Nonin Medical. "It will serve as a great benefit to all areas of healthcare."

Envisioning the shift of healthcare, Nonin Medical has implemented technologies throughout its product offering to ensure adherence to these new open standards. "Nonin has made its vision of streamlined interoperable solutions and information exchange a reality by playing an integral role in the development of new open standards," says Jayant Parthasarathy, Ph.D., Technology Program Manager for Nonin Medical and Vice Chair of Continua's Technical Working Group. "These cross industry efforts in Continua, Bluetooth, USB and IEEE will enable interoperability among medical and consumer devices and ultimately empower individuals to better manage their health.

About Nonin Medical, Inc. -- http://www.nonin.com

Minneapolis-based Nonin Medical, Inc., a privately owned company specializing in the design and manufacture of physiological monitor
'/>"/>

SOURCE Nonin Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Noninvasive tests for cirrhosis may help to avoid liver biopsy
2. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
3. Nonin Medical is Honored With Niche Supplier Award from Amerinet
4. Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
5. Noninvasive ways to assess liver disease
6. Cerimon to Conduct a Proof of Concept Study for Basiliximab for Noninfectious Uveitis, a Potentially Sight-Threatening Inflammation of the Eye
7. Nonin Medical, Inc. Is Recognized for Its Role in Promoting Interoperability
8. Advancing Interoperability - Nonin(R) Medical Unveils Worlds First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter
9. Noninvasive Procedures Show Promise for Esophageal Bleeding
10. Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin
11. Nonin(R) Medical Pioneers First Interoperable, Wireless Fingertip Pulse Oximeter
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Cambodia 3A World AIDS Day HIV Campaign Testing Millions to Again Launch During Cambodias National Water Festival 60453 1Cambodia 3A World AIDS Day HIV Campaign Testing Millions to Again Launch During Cambodias National Water Festival 60453 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 1Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 3NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 1NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 3